drugset / Trial / NCT07803133

PENG Block Versus Intrathecal Morphine for Early Postoperative Recovery After Total Hip Arthroplasty

NCT07803133 ↗

Not yet recruiting 90 enrolled Erzincan Binali Yildirim Universitesi
RandomizedParallel-groupSingle-blindTreatment

Summary

The goal of this clinical trial is to compare the PENG block with intrathecal morphine for early postoperative recovery and pain control in adults undergoing elective total hip arthroplasty. The main question it aims to answer is: Is there a difference between PENG block and intrathecal morphine in quality of recovery 24 hours after surgery, as measured by the Quality of Recovery-15 (QoR-15) questionnaire? Researchers will also compare postoperative pain, opioid use, mobilization, motor function, and treatment-related side effects between the two groups. Participants will be randomly assigned to receive either a PENG block or intrathecal morphine in addition to spinal anesthesia and standard multimodal pain treatment. Participants will complete the QoR-15 questionnaire before surgery and 24 hours after surgery. Pain scores, opioid use, mobilization, motor function, and side effects will be assessed during the first 24 hours after surgery.

Timeline

Start
2026-09-01
Primary completion
2027-09-01
Completion
2027-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Morphine Other / unclassified 100 ug Intrathecal

Indications

No indication recorded.